Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) which are the most effective agents for the treatment of gastroesophageal reflux disease (GERD), have been known to delay gastric emptying. Mosapride has been used as prokinetics by accelerating gastric emptying. We evaluated the efficacy of mosapride t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lim, Hyun Chul, Kim, Jie-Hyun, Youn, Young Hoon, Lee, Eun Hee, Lee, Byung Keon, Park, Hyojin
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Neurogastroenterology and Motility 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816184/
https://ncbi.nlm.nih.gov/pubmed/24199010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm.2013.19.4.495
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars